Jan 30, 2020
Notice of Distribution of Retained Earnings
Name of listed company: | Chugai Pharmaceutical Co., Ltd. |
Code number: | 4519 (1st Section of Tokyo Stock Exchange) |
Head office: | 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo |
President & CEO: | Tatsuro Kosaka |
Inquiries to: | Masahiko Uchida, |
General Manager, Corporate Communications Dept. | |
Tel:+81-(0)3-3273-0881 |
Chugai Pharmaceutical Co., Ltd. announced today that the Company resolved at the meeting of its Board of Directors held today to distribute retained earnings with the record date being December 31, 2019, as described below. This matter will be submitted to the 109th Annual General Meeting of Shareholders scheduled to be held on March 30, 2020.
1. Contents of Dividends
Amount decided | Latest forecast for dividend (October 24, 2019) | Actual in the previous fiscal year (ended Dec. 31, 2018) | |
---|---|---|---|
Record date | December 31, 2019 | December 31, 2019 | December 31, 2018 |
Dividends per share | JPY92.00 | Undecided | JPY55.00 |
Total dividends | JPY50,372 million | ― | JPY30,097 million |
Effective date | March 31, 2020 | ― | March 29, 2019 |
Dividend resource | Accumulated profit | ― | Accumulated profit |
2. Reasons for the Revision
Regarding income distribution, taking into account the strategic funding needs and earnings prospects, Chugai aims for a consolidated dividend payout ratio of 50% on average in comparison with Core EPS to provide a stable allocation of profit to all shareholders. In addition, internal reserves will be used to increase corporate value through investments to attain further growth in existing strategic domains and to identify future business opportunities.
In the fiscal year ended December 31, 2019, the Company achieved the highest results in the past and increased Core EPS by 73.3% year-on-year.
Reflecting the favorable results and based on our principles of “aiming a consolidated dividend payout ratio of 50% on average in comparison with Core EPS to provide a stable allocation of profit,” year-end dividend for the fiscal year ended December 31, 2019 is planned to be JPY92 per share, which is sum of JPY48 as regular dividend and JPY44 as special dividend. As a result, total dividend for the fiscal year under review will be JPY140 per share, and the Core dividend payout ratio is 45.8% (an average of 47.4% for the past five years).
(For reference) Contents of annual dividends:
Dividend per share | |||
---|---|---|---|
End of second quarter | End of fiscal year | Total | |
Fiscal year ended Dec. 2019 |
JPY48.00 | JPY92.00 | JPY140.00 |
Fiscal year ended Dec. 2018 |
JPY31.00 | JPY55.00 | JPY86.00 |
Contact:
- For Media
- Chugai Pharmaceutical Co., Ltd.
- Media Relations Group, Corporate Communications Dept.,
- Tomoko Shimizu
- Tel: +81-3-3273-0881
- E-mail: pr@chugai-pharm.co.jp
- For Investors
- Chugai Pharmaceutical Co., Ltd.
- Investor Relations Group, Corporate Communications Dept.,
- Toshiya Sasai
- Tel: +81-3-3273-0554
- E-mail: ir@chugai-pharm.co.jp